Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: Los Angeles CA, Los Alamitos CA, Duarte CA, Irvine CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase 3, Recruiting
Safety and Effectiveness of the CustomFlex Artificial Iris Prosthesis for the Treatment of Iris Defects
for
Full Aniridia, Partial Aniridia
Location: Los Angeles CA, Cincinnati OH, Philadelphia PA
Sponsor: Clinical Research Consultants, Inc.
Sex: All
Age: 3+
Code: NCT01860612
Recruiting
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
for
Small Cell Lung Carcinoma, Neuroendocrine Neoplasms,
Location: Los Angeles CA, San Francisco CA, Phoenix AZ,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT05882058
Phase 2, Recruiting
Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
for
Recessive Dystrophic Epidermolysis Bullosa
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 7+
Code: NCT03392909
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
for
High-grade Serous Ovarian Carcinoma (HGSOC),
Location: Los Angeles CA, Vancouver, Toronto, Hackensack NJ,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06476808
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
for
Bladder Carcinoma, Genitourinary System Neoplasm,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT05519878
Recruiting
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: El Segundo CA, Newport Beach CA
Sponsor: ImmunityBio, Inc.
Sex: Female
Age: 18 - 70+
Code: NCT06710288
Phase 2, Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Santa Clarita CA, San Dimas CA, Orange CA, Tustin CA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase 3, Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
Location: Beverly Hills CA, Los Angeles CA, Fullerton CA,
Sponsor: Fate Therapeutics
Sex: All
Age: 12 - 70
Code: NCT06308978
Phase 1, Recruiting
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
for
B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma,
Location: Los Angeles CA, Duarte CA, Portland OR, Denver CO,
Sponsor: Vironexis Biotherapeutics Inc.
Sex: All
Age: 13 - 70+
Code: NCT06533579
Phase 1, Phase 2, Recruiting
A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Whittier CA, Baltimore MD
Sponsor: Zhejiang Haichang Biotech Co., Ltd.
Sex: All
Age: 18+
Code: NCT05267899
Phase 1, Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Burbank CA, Phoenix AZ, Reno NV, Grand Junction CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06170788
Phase 3, Recruiting
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
for
T-Cell Neoplasm, Lymphoproliferative Disorders
Location: Duarte CA, Ann Arbor MI, Columbus OH, Durham NC
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT04858256
Phase 2, Recruiting
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
for
Hypogammaglobulinemia, Bacterial Infections,
Location: Huntington Park CA, Bullhead City AZ, Canton OH,
Sponsor: Grifols Therapeutics LLC
Sex: All
Age: 18+
Code: NCT05645107
Phase 3, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Bellflower CA, Moorpark CA, Temecula CA, Las Vegas NV,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase 2, Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Los Angeles CA, Duarte CA, Eugene OR, Portland OR,
Sponsor: Incyte Corporation
Sex: Female
Age: 18+
Code: NCT07214779
Phase 3, Recruiting
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Los Angeles CA, Dallas TX, Houston TX, Ann Arbor MI,
Sponsor: LigaChem Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05941507
Phase 1, Phase 2, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Burbank CA, La Jolla CA, Palo Alto CA,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase 3, Recruiting
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
for
Necrotizing Soft Tissue Infection
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06002607
Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: Los Angeles CA, Beverly Hills CA, La Jolla CA,